- Home
- EQBK vs ORGO Comparison
EQBK vs ORGO Comparison
Compare EQBK & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQBK
- ORGO
- Stock Information
- Founded
- EQBK 2002
- ORGO 1985
- Country
- EQBK United States
- ORGO United States
- Employees
- EQBK N/A
- ORGO N/A
- Industry
- EQBK Major Banks
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- EQBK Finance
- ORGO Health Care
- Exchange
- EQBK Nasdaq
- ORGO Nasdaq
- Market Cap
- EQBK 773.5M
- ORGO 620.3M
- IPO Year
- EQBK 2015
- ORGO N/A
- Fundamental
- Price
- EQBK $41.00
- ORGO $4.62
- Analyst Decision
- EQBK Buy
- ORGO Buy
- Analyst Count
- EQBK 6
- ORGO 2
- Target Price
- EQBK $46.20
- ORGO $7.50
- AVG Volume (30 Days)
- EQBK 86.5K
- ORGO 763.0K
- Earning Date
- EQBK 10-14-2025
- ORGO 11-11-2025
- Dividend Yield
- EQBK 1.45%
- ORGO N/A
- EPS Growth
- EQBK 532.31
- ORGO N/A
- EPS
- EQBK 4.01
- ORGO N/A
- Revenue
- EQBK $227,628,000.00
- ORGO $429,531,000.00
- Revenue This Year
- EQBK $19.34
- ORGO $2.57
- Revenue Next Year
- EQBK $11.25
- ORGO $9.80
- P/E Ratio
- EQBK $10.34
- ORGO N/A
- Revenue Growth
- EQBK 48.83
- ORGO N/A
- 52 Week Low
- EQBK $34.11
- ORGO $2.61
- 52 Week High
- EQBK $50.85
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- EQBK 51.28
- ORGO 44.62
- Support Level
- EQBK $40.10
- ORGO $4.75
- Resistance Level
- EQBK $42.31
- ORGO $5.10
- Average True Range (ATR)
- EQBK 1.01
- ORGO 0.21
- MACD
- EQBK -0.15
- ORGO -0.04
- Stochastic Oscillator
- EQBK 35.36
- ORGO 4.96
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.